Pricing news

Every pricing development we have covered, newest first.

Direct answer

5 dated pricing items. Most recent: Lilly Q2: volume up 60%, realised prices down 13% (2026-08-05).

All-in monthly cost at 10 mg

NexLife$215Yucca Health$258Mochi Health$278IVIM Health$278Found$289ShedRx$289SkinnyRx$299Amble Health$300Henry Meds$349TrimRx$349Lavender Sky Health$352Join Fridays$359
Medication plus any recurring membership fee, at 10 mg. Lower is better. Captured 2026-08-05.

What this beat covers

What programmes charge, when it changes, and what the change does to a first-year total. This beat exists because compounded GLP-1 pricing is not sticky: rates move on promotion cycles, on prepaid-term restructuring and on the cost of the active ingredient, and a figure published without a date stops being a fact within weeks.

We log a price movement when we can date it and source it. A rate that appears in a third-party round-up but not on the programme's own page is recorded as third-party and labelled, because the failure mode we most want to avoid is presenting an unconfirmed figure as a confirmed one.

The item worth watching in this beat is not the headline rate but the structure underneath it: whether a cut applies at every dose or only at the starter dose, and whether it requires a prepaid term. Both are ways of lowering an advertised number without lowering a bill.

Stories in this category

How to read a dated item

Every story carries the date we recorded it and links to what we read. Nothing here is undated, because an undated claim about a market that reprices this often is not usable. Where an item concerns a price, the figure is repeated with its dose and its fee basis attached rather than left to be inferred from the headline.

If an item is wrong, it gets a correction with a date rather than a silent edit. The full log is at corrections, and it includes errors we found in our own work.

Primary sources

Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.

  1. FDA — Human Drug Compounding
  2. FDA — Warning Letters
  3. FDA — Drug Shortages
  4. FTC — Health Products Compliance Guidance
  5. FDA — Counterfeit medicine